isavuconazole and Osteomyelitis

isavuconazole has been researched along with Osteomyelitis* in 1 studies

Other Studies

1 other study(ies) available for isavuconazole and Osteomyelitis

ArticleYear
Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:5

    A 65-year-old man was diagnosed with an invasive Aspergillus fumigatus infection with sternal osteomyelitis 4 months after heart transplantation. Unfortunately, after 8 weeks patient developed severe cutaneous and neurological toxicities induced by voriconazole leading to drug discontinuation. Therefore, isavuconazole was chosen as second-line therapy. The patient presented a favorable outcome and tolerance was excellent after ten months monotherapy. Here, we report for a first time, an successful isavuconazole-based treatment of sternal osteomyelitis aspergillosis in a cardiac recipient.

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Heart Transplantation; Humans; Male; Nitriles; Osteomyelitis; Pyridines; Triazoles; Voriconazole

2020